THE proliferation of malignant cells has been shown to depend not only on intrinsic neoplastic properties but also on environmental circumstances, in vivo (host) or in vitro (medium). In addition, a changing rate of growth in a continuing environment has been documented in tumor-bearing hosts and tissue culture situations. The kinetics of neoplastic cells (i.e. Ehrlich ascites tumor cells-EAT) have been studied with regard to cellular proliferation within cell-tight millipore chambers by Amos and Wakefield (1958) (among others), particularly concerning the growth rate of cells in normal mice and the rate of entry of iso-antibody into the chambers. The present investigations define the growth pattern of Ehrlich ascites tumor cells within the restricted environment of millipore chambers in actively immunized mice.
White Swiss mice of both sexes (HA/ICR strain), 3-4 months old, were used in this study. The tumor cells used were Lettre strain, hyperdiploid Ehrlich ascites tumor originally obtained from Roswell Park Memorial Institute and grown locally through passage in HA/ICR mice. Millipore chambers, 14 mm. x 2 mm., were used. The rings were No. PROO01401, with filling holes, and the filters used were No. HAWPO1400, with a porosity of 0 45 microns. The chambers were assembled using MF cement No. 1. Fresh peritoneal fluid from an 8-day tumorbearing mouse was harvested and cell counts obtained. A sterile preparation of ten million cells per cu. ml. in normal saline was then prepared. One-tenth ml. of this suspension (one million cells) was then injected into the chamber and the hole plugged by special nylon thread. The chambers were then implanted intraperitoneally in the designated mice.
Mice were anesthetized using 10% Dibutal in doses of 025 ml. to 0 4 ml. A depilatory agent (Nair) was used to remove hair, and a 1-inch incision was made using sterile precautions in the lower right quadrant of the abdomen for placement of the chamber intraperitoneally. The wound was closed with two 9 mm. metal clips and Neomycin powder applied. The metal clips were removed from the mice 2 days post-operatively. At specific times, the chambers were withdrawn and thoroughly washed in saline to remove all tissue, cells, and debris on the outside. The filters were then freed from the ring, and all parts were dropped into a 50 ml. sterile tube containing 2 ml. of normal saline. The tube and the contents were vigorously agitated on a Vortex junior mixer for 5 minutes to break up tumor clumps and suspend all cells equally in the saline. The suspension was filtered through a small piece of glass wool to remove filter particles. Cell counts were performed on this suspension using a hemocytometer and the total number of cells contained in the chamber calculated.
Antigen for immunization was obtained from the peritoneal cavity of tumorbearing mice. Peritoneal fluid was centrifuged in a graduated tube to note packed cell volume. The supernatant was discarded and the cells resuspended in an equal volume of 0.85oo saline. This suspension was then dispersed in 2 ml. aliquots for lyophilization and storage (each tube then contained the dried constituents of 1 ml. of tumor cells). Before injection, 1 ml. of 0.85% saline and I ml. of Freund's complete adjuvant were added to this dried powder and the components thoroughly mixed for 10 minutes on a Vortex junior mixer. The following schedule for injectons was used:
Day 1. EAT growth curve in chambers in normal mice ( Fig. 1) Forty-one mice were used in deriving this normal growth curve. Readings were taken at 2-day intervals using at least 2 mice for each determination. When changes in rate were taking place rapidly, larger numbers of mice were used in determining cell counts of chambers to ensure accuracy. The growth " curve " represents a smooth curve drawn between points representing average cell counts found at specified times.
Tumor cell growth was first characterized by an exponential increase in the number of cells, with little if any initial lag in this system. Beginning with 1 x 106 cells per chamber, there was an increase to 6 x 106 cells. This initial phase was followed by a period in which the total cell counts per chamber approached an asymptote with approximately 8-5 x 106 cells per chamber.
2. EAT growth rate in chambers in immune mice ( Fig. 1) Growth rate curves in immune mice were determined in the same manner as in normal mice, beginning with 1 x 106 cells in the chambers and sampling at 2-day intervals. In Fig. 1 , it can be seen that there was similar proliferation up to the fourth day. After this time, varying amounts of cell destruction were observed. This 4-day period of similar growth may represent the time needed for equilibration of humoral cytotoxic substances between the peritoneal fluid and the chamber. It appears that the longer the mouse had been immune before receiving the chamber with EAT, the greater the amount of cell destruction seen after the 4-day period. The EAT cells were not completely eliminated by the immune mice within the chambers at any of the time intervals. 
Control studies on cell counting evaluation
To check for cell loss during the counting procedure outlined above, the ring and filters were resuspended in 2 ml. of saline and thoroughly agitated. Additional cell counts were done on the supernatant. The glass wool filter was treated by vigorous agitation. suspended in saline, and cell counts done on this supernatant also. These controls produced negligible cell counts, thereby indicating that the methods used accounted for approximately 9700 of the cells. Therefore, few cells (approximately 30 ) had remained attached to the ring or the filters themselves, and few were lost in the glass wool filter. Cell clumps were encountered rarely in the chamber fluid, thereby enabling the use of the glass wool filter without gross cell loss.
To check for possible migration of cells through the filters, 6 normal mice received empty chambers intraperitoneally. Four days later, these mice were inoculated with 0-2 ml. of undiluted fresh tumor fluid. At 10-14 days, when these mice were grossly distended with EAT, they were killed and the chambers examined. These chambers were filled with peritoneal fluid, but there were no cells (EAT, or normal WBC's) seen microscopically, indicating no, or at least very minimal, passage of EAT through the filters from an area of massive tumor concentration in the peritoneal cavity to the inside of the chamber. Animals followed for 60-90 days after EAT-chamber placement did not develop the tumor, even when the chambers remained intraperitoneally, indicating no, or minimal, migration from within a chamber out into the peritoneal cavity.
DISCUSSION
The method of study used here necessarily influences the growth of intraperitoneal EAT by circumstances non-operative in the absence of millipore chambers. This investigation was specifically aimed at the evaluation of EAT proliferation inside millipore chambers, a circumstance combining an in vivo environment with an in vitro accounting of total cells. The derived growth curves show exponential growth of EAT essentially without a lag phase, followed by a leveling period. Capalbo, Albright and Bennett (1964) have shown that small numbers of white blood cells can apparently pass through chambers with a 0.45 ,u pore size. The passage of EAT cells did not appear to be a factor in this study, since reverse passage into empty chambers could not be documented, nor did mice with EAT in chambers develop tumors on prolonged follow-up.
Quantitative approaches to ascites tumor growth in mice previously reported include those of Patt and Blackford (1954) , Klein and Revesz (1953), and Baserga (1963) . Many of these studies deal with the estimation of the number of free tumor cells in the peritoneal cavity. The growth curves described resemble those obtained in the present study, with exponential growth followed by a leveling phase. EAT cells in tissue culture also show a similar phasic proliferation.
The growth of EAT in passively immunized mice has been investigated by several groups, including Lindner (1958 Lindner ( , 1960 and Levi et al. (1959) , and such studies demonstrate immune inhibition (Amos and Wakefield, 1958) . Also, Harveit (1963 , 1962 , who has done considerable work with the mouse-EAT system, has shown a. cytotoxic factor in the ascitic fluid and has also demonstrated production of active immunization to EAT in mice. However, quantitative studies in actively immunized mice have been largely bypassed, perhaps due to the heterogeneity of the immune response in a group of mice.
The growth of EAT within millipore chambers in actively immunized mice demonstrates inhibition of EAT growth. The EAT cells were not completely destroyed however, but apparently survived at a reduced rate of growth. In those animals that were immunized and later challenged by EAT, immunity was significant but not complete. Variation was noted in fact, regarding tumor challenge in both the normal and immunized mice.
The nature of this mechanism has not been identified by this study. Considerations include the possible transfer of: (a) classic antibody with or without complement, (b) the immune lymphocyte factor of Lawrence et al. (1963) , (c) immune lymphocyte RNA (Mannick and Egdahl, 1964) , (d) other factors to affect EAT cells either directly or in conjunction with trapped leukocytes, and (e) mononuclear cells, though probably in insufficient quantity in this study to achieve the result appreciated by themselves.
SUMMARY
This investigation documents the quantitative growth of EAT cells in normal and actively immunized mice, using an in vivo millipore chamber technique. The presence of an inhibitor of EAT cell growth was demonstrated in actively immunized mice.
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